Professor Cherry Wainwright c.wainwright@rgu.ac.uk
Professor
sFRPs as a novel modulator of diastolic heart failure
People Involved
Dr Sarah Walsh s.walsh@rgu.ac.uk
Research Fellow
Short-term oral administration of the Porcupine inhibitor, Wnt-c59, improves the structural and functional features of experimental HFpEF. (2025)
Journal Article
WALSH, S.K. [2025]. Short-term oral administration of the Porcupine inhibitor, Wnt-c59, improves the structural and functional features of experimental HFpEF. Pharmacology research and perspectives [online], (accepted).Heart failure with preserved ejection fraction (HFpEF) accounts for approximately 50% of heart failure cases globally, and this incidence is increasing due to extended lifespans and accumulating comorbidities. Emerging evidence suggests that Wnt sign... Read More about Short-term oral administration of the Porcupine inhibitor, Wnt-c59, improves the structural and functional features of experimental HFpEF..